Anti herpes simplex virus-2 activity of the extracts of Sericostoma pauciflorum stocks ex wight and Lepidagathis trinervis Nees


Original Article

Author Details : Boskey Pancholi*

Volume : 9, Issue : 3, Year : 2022

Article Page : 177-182

https://doi.org/10.18231/j.ijmr.2022.032



Suggest article by email

Get Permission

Abstract

Aims: To determine the anti-HSV 2 properties and mechanism of action of two important medicinal plants Sericostoma pauciflorum Stocks exWight (Boraginaceae) and Lepidagathis trinervis Nees (Acanthaceae).
Methods and Results: To identify natural products with anti-HSV-2 activity, the aqueous and 50% ethanolic extracts were prepared from whole plants of S. pauciflorum and L. trinervis. Cytotoxicity assay using Vero cells as target revealed CC50 values of these extracts ranging from 301.8 to 436.8 µg ml-1.  Extracts from both the plants showed dose dependent inhibition of HSV-2 infection using Plaque Reduction Assay. Among the tested extracts, 50% ethanolic extract of L. trinervis showed lowest IC50 value of 6.86
µg ml-1. To study the possible mode of antiviral action, all the extracts showed 50 to 97% reduction in the formation of plaques in the attachment assay. Extracts prepared from L. trinervis also inhibited the HSV-2 penetration in a time and dose dependent manner. In post-attachment assay, both the extracts from S. pauciflorum as well as 50% ethanolic extract from L. trinervis showed significant inhibition in HSV-2 infection.
Conclusions: These studies document anti-HSV-2 activity of the two commonly used medicinal plants that will have implications in the development of an alternate remedy for HSV-2 infection.      

Keywords : Sericostoma pauciflorum, Lepidagathis trinervis, anti­ HSV­ 2 activity, Attachment assay, Penetration assay, Post­ attachment assay 3


How to cite : Pancholi B, Anti herpes simplex virus-2 activity of the extracts of Sericostoma pauciflorum stocks ex wight and Lepidagathis trinervis Nees. Indian J Microbiol Res 2022;9(3):177-182


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.







Article History

Received : 13-08-2022

Accepted : 07-09-2022


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijmr.2022.032


Article Metrics






Article Access statistics

Viewed: 601

PDF Downloaded: 234



Medical Abbreviation List